Advertisement

Index by author

September 01, 2024; Volume 390,Issue 3

  1. Anderson, Benjamin D.

    1. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Open Access
      High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Benjamin D. Anderson, Diana E. Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D. Coates, Aviauna Beckett, Jordan E. Bisanz, Joshua J. Kellogg and Wesley M. Raup-Konsavage
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 331-341; DOI: https://doi.org/10.1124/jpet.124.002204

  2. Arimoto, Mayuka

    1. Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans
      Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans
      Shinji Kobuchi, Mayuka Arimoto and Yukako Ito
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 318-330; DOI: https://doi.org/10.1124/jpet.124.002260

  3. Balint, Hallie

    1. Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice
      Clare M. Diester, Hallie Balint, James C. Gillespie, Aron H. Lichtman, Laura J. Sim-Selley, Dana E. Selley and S. Stevens Negus
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 291-301; DOI: https://doi.org/10.1124/jpet.123.001940

  4. Beckett, Aviauna

    1. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Open Access
      High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Benjamin D. Anderson, Diana E. Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D. Coates, Aviauna Beckett, Jordan E. Bisanz, Joshua J. Kellogg and Wesley M. Raup-Konsavage
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 331-341; DOI: https://doi.org/10.1124/jpet.124.002204

  5. Beltrame, John F.

    1. Developing Novel Therapies in Coronary Vasomotor Disorders: Translational Gaps from Basic Science to Clinical Impact
      John F. Beltrame and David P. Wilson
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 277-279; DOI: https://doi.org/10.1124/jpet.124.002159

  6. Bisanz, Jordan E.

    1. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Open Access
      High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Benjamin D. Anderson, Diana E. Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D. Coates, Aviauna Beckett, Jordan E. Bisanz, Joshua J. Kellogg and Wesley M. Raup-Konsavage
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 331-341; DOI: https://doi.org/10.1124/jpet.124.002204

  7. Burgard, Edward C.

    1. Recent Developments in On-Demand Voiding Therapies
      Recent Developments in On-Demand Voiding Therapies
      Karl B. Thor, Lesley Marson, Mary A. Katofiasc, Daniel J. Ricca and Edward C. Burgard
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 302-317; DOI: https://doi.org/10.1124/jpet.123.002073

  8. Coates, Matthew D.

    1. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Open Access
      High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Benjamin D. Anderson, Diana E. Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D. Coates, Aviauna Beckett, Jordan E. Bisanz, Joshua J. Kellogg and Wesley M. Raup-Konsavage
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 331-341; DOI: https://doi.org/10.1124/jpet.124.002204

  9. Cortez-resendiz, Alonso

    1. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Open Access
      High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model
      Benjamin D. Anderson, Diana E. Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D. Coates, Aviauna Beckett, Jordan E. Bisanz, Joshua J. Kellogg and Wesley M. Raup-Konsavage
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 331-341; DOI: https://doi.org/10.1124/jpet.124.002204

  10. Diester, Clare M.

    1. Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice
      Clare M. Diester, Hallie Balint, James C. Gillespie, Aron H. Lichtman, Laura J. Sim-Selley, Dana E. Selley and S. Stevens Negus
      Journal of Pharmacology and Experimental Therapeutics September 2024, 390 (3) 291-301; DOI: https://doi.org/10.1124/jpet.123.001940
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement